Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TK inhibitors under development at Dr. Karl Thomae

Nov. 13, 1997

Sankyo synthesizes azole aromatase inhibitors

Nov. 13, 1997

Mitsui Toatsu reveals novel antitumor agents

Nov. 12, 1997

Radicicol derivatives with antitumor activity from Sankyo

Nov. 12, 1997

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

Spotlight on topoisomerase I inhibitors

Nov. 12, 1997

DepoCyt to be reviewed by FDA advisory committee this month

Nov. 11, 1997

NCI supports R&D on antiangiogenic agents at Telios

Nov. 10, 1997

New taxoids from RPR

Nov. 10, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...